TNFSF18 and neoplasm: These findings suggested that GITRL could relieve the suppression mediated by highly activated tumor-infiltrating Tregs, being a potential immunotherapeutic agent characterized by anti-tumor T cell activity within the tumor microenvironment [82,94].